Post Hoc analyses of GOG 9923: Does BRCA status affect toxicities?: an NRG Oncology Study

OBJECTIVE: To evaluate how women with epithelial ovarian cancer (EOC), dichotomized by BRCA status, tolerate intravenous (IV) or intraperitoneal (IP) chemotherapy given with veliparib and bevacizumab (bev) on a GOG phase I study (GOG 9923, NCT00989651). METHODS: This is an unplanned, post hoc analys...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gynecol Oncol
Egile Nagusiak: Gillen, Jessica, Miller, Austin, Bell-McGuinn, Katherine M, Schilder, Russell J, Walker, Joan L, Mathews, Cara A., Duska, Linda R., Guntupalli, Saketh R, O’Cearbhaill, Roisin, Hays, John, Hagemann, Andrea R., Gray, Heidi J., Gordon, Sarah W., Armstrong, Deborah K., Chen, Alice, Fracasso, Paula M., Aghajanian, Carol, Moore, Kathleen N.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8084973/
https://ncbi.nlm.nih.gov/pubmed/33610319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2021.01.037
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak